Skip to content
Clinical Trials – home
IrelandBack to Ireland

Clinical trials in Cork – page 4

159 clinical trials in Cork, Ireland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Cork at a glance
159
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

159 trials in Cork

Open in trial search

Anaemia+1

Recruiting

Study of Elritercept for Treating Anemia in Adults with Low to Intermediate Risk Myelodysplastic Syndromes

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Elritercept
  • Sponsor:Takeda Development Center Americas Inc.

Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:University Of Cologne

Study on Revumenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Endometrial cancer+13

Recruiting

Study on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Ifinatamab Deruxtecan
  • Sponsor:Daiichi Sankyo Inc.

Study of Opevesostat, Olaparib, and Cabazitaxel in Patients with Advanced Prostate Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Merck Sharp & Dohme LLC

Study on Early Treatment of Patent Ductus Arteriosus with Paracetamol in Extremely Low Birth Weight Infants

Registered drug
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Paracetamol
  • Sponsor:University College Dublin
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Paclitaxel
  • Sponsor:Cancer Trials Ireland

Study of Elenestinib for Patients with Indolent Systemic Mastocytosis

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Elenestinib Phosphate
  • Sponsor:Blueprint Medicines Corp.

Study of Pembrolizumab and V940 for Treating Non-Small Cell Lung Cancer in Patients with Resectable Stage II to IIIB (N2) Not Achieving Complete Response

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC
Countries:IrelandIreland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amoxicillin Sodium
  • Sponsor:Universitair Medisch Centrum Utrecht

Study Comparing Givinostat and Hydroxyurea for Patients with High-Risk Polycythemia Vera

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Carbasalate Calcium
  • Sponsor:Italfarmaco S.p.A.

Premature baby

Recruiting

Study on the Effects of 30% vs. 60% Oxygen Levels at Birth for Improving Development in Premature Infants

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Oxygen Ph.eur.
  • Sponsor:University College Cork

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Cork

What the registry says about research in the country

01 Oncology Research

Extensive clinical trials focusing on lung cancer treatments, including innovative therapies for non-small cell lung cancer and testing new drug combinations. Studies evaluating treatments for breast cancer, particularly in hormone receptor-positive and HER2-negative variants.

  • Advanced Lung Cancer Treatments
  • Breast Cancer Therapies
  • Prostate Cancer Studies

Multiple trials exploring combination therapies and novel treatment approaches for various cancer types.

02 Hematologic Disorders

Research initiatives examining treatments for chronic lymphocytic leukemia and lymphomas. Studies evaluating new therapeutic approaches for myelodysplastic syndromes, focusing on reducing transfusion dependency.

  • Leukemia Treatments
  • Lymphoma Therapies
  • Blood Disorders Management

Innovative approaches combining multiple therapeutic agents to improve patient outcomes.

03 Autoimmune Conditions

Clinical studies investigating treatments for Primary Sjögren's Disease and atopic dermatitis. Research on novel therapeutic approaches for inflammatory conditions and immune system disorders.

  • Inflammatory Disease Treatments
  • Skin Condition Therapies
  • Immune System Modulation

Focus on developing targeted therapies to improve patient quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.